|
|
| | Aurora Kinase Inhibitor III Basic information |
| Product Name: | Aurora Kinase Inhibitor III | | Synonyms: | Aurora Kinase Inhibitor III;Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide;N-[3-[[4-[3-(trifluoromethyl)anilino]pyrimidin-2-yl]amino]phenyl]cyclopropanecarboxamide;AKI-7169;Aurora Kinase Inhibitor III - CAS 879127-16-9 - Calbiochem;Aurora Kinase Inhibitor 3;Cyclopropanecarboxamide, N-[3-[[4-[[3-(trifluoromethyl)phenyl]amino]-2-pyrimidinyl]amino]phenyl]-;Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide >=98% (HPLC), solid | | CAS: | 879127-16-9 | | MF: | C21H18F3N5O | | MW: | 413.4 | | EINECS: | | | Product Categories: | | | Mol File: | 879127-16-9.mol |  |
| | Aurora Kinase Inhibitor III Chemical Properties |
| density | 1.456±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | H2O: <2mg/mL | | pka | 14.51±0.70(Predicted) | | form | White solid | | color | white |
| | Aurora Kinase Inhibitor III Usage And Synthesis |
| General Description | A cell-permeable 2,4-dianilinopyrimidine compound that acts as an ATP-competitive, potent, but non-selective inhibitor of Aurora A (IC50 = 42 nM). At higher concentrations, also inhibits the activities of other kinases, such as Lck, Bmx, IGF-1R, and Syk (IC50 = 131, 386, 591, and 887 nM, respectively). | | Biochem/physiol Actions | Target IC50: 42 nM against Aurora A; 131, 386, 591, and 887 nM, against Lck, Bmx, IGF-1R, and Syk , respectively |
| | Aurora Kinase Inhibitor III Preparation Products And Raw materials |
|